NASDAQ:NSTG - NanoString Technologies Stock Price, News & Analysis

$21.85
-0.13 (-0.59 %)
(As of 09/15/2019 05:52 AM ET)
Today's Range
$21.5850
Now: $21.85
$22.09
50-Day Range
$21.64
MA: $26.29
$33.45
52-Week Range
$13.26
Now: $21.85
$34.78
Volume294,947 shs
Average Volume506,947 shs
Market Capitalization$774.36 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22
NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$106.73 million
Book Value$1.20 per share

Profitability

Net Income$-77,400,000.00

Miscellaneous

Employees476
Market Cap$774.36 million
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.


NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

How were NanoString Technologies' earnings last quarter?

NanoString Technologies Inc (NASDAQ:NSTG) announced its quarterly earnings results on Wednesday, July, 31st. The biotechnology company reported ($0.57) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.55) by $0.02. The biotechnology company earned $30.35 million during the quarter, compared to the consensus estimate of $29 million. NanoString Technologies had a negative net margin of 68.16% and a negative return on equity of 118.03%. View NanoString Technologies' Earnings History.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for NanoString Technologies.

What guidance has NanoString Technologies issued on next quarter's earnings?

NanoString Technologies updated its FY 2019 earnings guidance on Wednesday, July, 31st. The company provided EPS guidance of $-2.4--2.2 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-2.24. The company issued revenue guidance of $118-123 million, compared to the consensus revenue estimate of $120.83 million.

What price target have analysts set for NSTG?

3 brokers have issued 12 month target prices for NanoString Technologies' stock. Their predictions range from $18.00 to $35.00. On average, they anticipate NanoString Technologies' stock price to reach $25.3333 in the next twelve months. This suggests a possible upside of 15.9% from the stock's current price. View Analyst Price Targets for NanoString Technologies.

What is the consensus analysts' recommendation for NanoString Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NanoString Technologies.

Has NanoString Technologies been receiving favorable news coverage?

News coverage about NSTG stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. NanoString Technologies earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for NanoString Technologies.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Bank Of The Ozarks (OZRK), Designer Brands (DSW) and Eaton Vance Floating-Rate Income Trust (EFT).

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the folowing people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 42)
  • Mr. K. Thomas Bailey M.B.A., CFO & Treasurer (Age 50)
  • Dr. Mary Tedd Allen, Sr. VP of Operations & Admin. (Age 56)
  • Dr. Joseph M. Beechem, Sr. VP of R&D (Age 61)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 52)

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by a number of of institutional and retail investors. Top institutional investors include ARK Investment Management LLC (10.06%), Morgan Stanley (9.15%), BlackRock Inc. (8.73%), Nikko Asset Management Americas Inc. (7.10%), Vanguard Group Inc. (4.88%) and Cadian Capital Management LP (4.31%). Company insiders that own NanoString Technologies stock include Charles P Waite, Jr, David W Ghesquiere, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, Nicholas Galakatos, R Bradley Gray and William Young. View Institutional Ownership Trends for NanoString Technologies.

Which institutional investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Bank of America Corp DE, Farallon Capital Management LLC, Cubist Systematic Strategies LLC, Platinum Investment Management Ltd., Bogle Investment Management L P DE, Sandler Capital Management and Lisanti Capital Growth LLC. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite, Jr, David W Ghesquiere, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, Nicholas Galakatos, R Bradley Gray and William Young. View Insider Buying and Selling for NanoString Technologies.

Which institutional investors are buying NanoString Technologies stock?

NSTG stock was purchased by a variety of institutional investors in the last quarter, including Nikko Asset Management Americas Inc., Cadian Capital Management LP, BlackRock Inc., Nuveen Asset Management LLC, Sumitomo Mitsui Trust Holdings Inc., Wells Fargo & Company MN, Vanguard Group Inc. and Citadel Advisors LLC. View Insider Buying and Selling for NanoString Technologies.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $21.85.

How big of a company is NanoString Technologies?

NanoString Technologies has a market capitalization of $774.36 million and generates $106.73 million in revenue each year. The biotechnology company earns $-77,400,000.00 in net income (profit) each year or ($2.78) on an earnings per share basis. NanoString Technologies employs 476 workers across the globe.View Additional Information About NanoString Technologies.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is http://www.nanostring.com/.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]


MarketBeat Community Rating for NanoString Technologies (NASDAQ NSTG)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  359 (Vote Outperform)
Underperform Votes:  336 (Vote Underperform)
Total Votes:  695
MarketBeat's community ratings are surveys of what our community members think about NanoString Technologies and other stocks. Vote "Outperform" if you believe NSTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Featured Article: Day Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel